Skip to main content
SNDX logo

SNDX · Syndax Pharmaceuticals Inc · Held by Funds

Track SNDX — free
$8.72 -0.41 (-4.49%) At close · Nov 20 Play latest call Q2 2026 earnings call transcript
Market Cap
$778.67M
Shares
89.30M
Volume · Nov 20 2.18M Avg daily vol (3M) 2.61M

Registered funds — mutual funds, ETFs and closed-end funds — whose latest Form N-PORT portfolio report holds this exact listed security, matched by CUSIP. Each row is one fund position with its size, value and weight in that fund.

Fund Ownership of SNDX by Fund Type

Registered funds' Form N-PORT reports for the quarter ended Jun 30, 2026

Index funds and index ETFs hold 18.50% of shares outstanding.

Fund type Of shares outstanding Shares
Index funds 3.40% 3,033,328
Index ETFs 15.10% 13,483,761
Active ETFs 0.26% 231,869
Active funds 9.56% 8,534,667
Unclassified 0.00% 1,692
All registered funds 28.32% 25,285,317
How fund types are measured

Each fund series counts once, with its latest Form N-PORT report dated inside the quarter; only long share positions count, restated to today's split basis. The fund type is the series' latest Form N-CEN answer on or before the quarter end (the index-fund box and the exchange-traded flag), never its name. Unclassified funds have no usable N-CEN; unit investment trusts are among them, so index ownership is a floor. Funds sit inside their advisers' 13F reports, so these shares overlap the 13F figures and are never added to them.

Funds holding SNDX

207 fund positions
Fund Balance Value % of Fund Open
Showing 1–50 of 207 positions
Key facts CIK 1395937 CUSIP 87164F105 13F (30d) 241 filings 222 filers Visit website Investor relations